Search for: "Tricore, Inc." Results 1 - 20 of 23
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Dec 2020, 9:44 am by Silver Law Group
Her previous employers include Tricor Financial, LLC (CRD#:142518) and Next Financial Group, Inc. [read post]
8 May 2011, 7:31 pm by Seyfarth Shaw LLP
Peoplemark, Inc., the Court in Tricore applied the well-established standard from Christiansburg Garment Co. v. [read post]
2 Mar 2017, 8:57 am by Seyfarth Shaw LLP
McLane Co., Inc., No. 15-1248 (2017), which will likely determine the standard of review for appellate courts considering district court decisions to either quash or enforce EEOC subpoenas (as we blogged about here), this ruling is an excellent victory for employers facing overly broad EEOC subpoenas. [read post]
28 Nov 2008, 12:49 pm
victories in fight for European BRCA patents (Holman's Biotech IP Blog) Europe: European Commission proposes strategy for dealing with rare diseases (Pharmacapsules @ Gowlings) US: Former House Ways and Means Economist claims 7-year data exclusive period is sufficient (Patent Docs) US: Medco predicts follow-on biologics regulatory pathway by 2011 (Patent Docs) US: Even after patent has expired, District Court has jurisdiction to set exclusivity date: In re Omeprazole Patent Litigation… [read post]
26 Mar 2014, 10:04 pm by Dan Flynn
Golden Boy was then owned by Tricore Pacific Capital Inc., but was in the process of being sold to Post Holdings Inc. [read post]
10 Jan 2009, 6:58 pm
Manhattan District Attorney Robert Morgenthau also said William Rapetti and his firm Rapetti Rigging Services Inc., Massapequa Park, N.Y., failed to file tax returns for 2006 and 2007. [read post]
9 Mar 2011, 3:00 am by Marie Louise
Allergan, Inc (Chicago IP Litigation Blog) Synagis (Palivizumab) – US: PDL BioPharma settles Medimmune Synagis litigation for $93M (Patent Docs) TriCor (Fenofibrate) – US: Abbott and Elan end TriCor suit with Ranbaxy (Patent Docs) Valsartan – Norway: Oslo District Court holds Actavis’ Valsartan/HCTZ product infringes Novartis’ patent covering synthesis route for Valsartan; deals inter alia with scope of Valsartan SPC (The SPC Blog) [read post]
7 Nov 2008, 3:42 am
Sandoz, Inc (Patent Docs) (PATracer) Boniva (Ibandronic acid) – US: Hoffman La Roche files third patent infringement lawsuit against Orchid over generic Boniva (GenericsWeb) Carbatrol (Carbamazepine) – US: Federal Judge grants summary judgment of noninfringement to Corepharma in Carbatrol patent dispute with Shire Laboratories (Law360) Effexor (Venlafaxine) – US: Wyeth settles with fourth drug company, Anchen Pharmaceuticals, over generic Effexor (Law360)… [read post]
7 Sep 2011, 4:22 am by Marie Louise
  Highlights this week included: US: CAFC: Immunisation methods are patent eligible: Classen Immunotherapies, Inc v Biogen IDEC et al (Inventive Step) (Orange Book Blog) (Patently-O) (Patent Docs) (Patent Docs) (IPBiz) (Patent Law Practice Center) (Patent Baristas) US: FTC issues long-awaited final report on authorized generics; report examines both the short-term effects and long-term impact on competition and drug prices (FDA Law Blog) (Orange Book Blog)   Please join the… [read post]
13 Nov 2008, 5:27 pm
  The Supreme Court's 2004 decision in Verizon Communications Inc. v. [read post]
30 Jan 2020, 10:49 am by luiza
  Correctional facilities operators Management and Training Corporation, Cornell Companies, Inc. [read post]
23 Aug 2008, 1:23 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
28 Mar 2008, 6:00 am
: (Afro-IP),If education and pricing policy fail, says Adobe in Nigeria, we can still sue: (Afro-IP),South African arm of Chrysler objects to advertisement by Indian vehicle maker Mahindra and Mahindra that uses the term "jeep": (Afro-IP), (Spicy IP),Kenya’s call for anti-counterfeit legislation… amongst other changes: (Afro-IP),Kenya: Shared computer use raises privacy, confidentiality issues: (Afro-IP)AustraliaChanges to grace period for trade mark renewal:… [read post]
28 Oct 2011, 7:06 am by John Hopkins
For example, between 2000 and 2004, Abbott was involved in the filing of 10 lawsuits in an attempt to block the generic distribution of its very profitable cholesterol lowering drug, TriCore. [read post]